Ernexa Therapeutics Advances Toward 2026 Human Trials.

Clinical Trial Updates: Schizophrenia Phase 3 Progress, ALS Study Launch & 2026 Human Trial Momentum

Clinical research continues to advance through pivotal psychiatry studies, neurodegenerative disease programs, and emerging therapeutic platforms preparing for first-in-human development.…